1887

New Health Technologies

Managing Access, Value and Sustainability

image of New Health Technologies

This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.

English

.

Achieving the promise of precision medicine

Precision medicine (PM) refines our understanding of disease prediction and risk, onset and progression in patients, informing better selection and development of evidence-based targeted therapies and associated diagnostics, by taking into account the patient’s genomic and other biological characteristics, as well as health status, medications patients are already prescribed and environmental and lifestyle factors.This chapter first describes the topic of PM, discussing its current application and challenges. These include establishment of economic incentives to develop biomarker testing and regulatory challenges such as market approval of companion diagnostics and treatments, Health Technology Assessment and coverage and funding decisions. Emerging trends in PM are then discussed, including next-generation sequencing (NGS) testing, patient-centric clinical trials, and sharing of data and knowledge.

English

Graphs

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error